ACOG
Price
$6.13
Change
+$0.01 (+0.16%)
Updated
Nov 13 closing price
Capitalization
122.7M
Intraday BUY SELL Signals
BLTE
Price
$112.41
Change
+$1.59 (+1.43%)
Updated
Nov 13 closing price
Capitalization
3.94B
133 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACOG vs BLTE

Header iconACOG vs BLTE Comparison
Open Charts ACOG vs BLTEBanner chart's image
Alpha Cognition
Price$6.13
Change+$0.01 (+0.16%)
Volume$77.77K
Capitalization122.7M
Belite Bio
Price$112.41
Change+$1.59 (+1.43%)
Volume$45.24K
Capitalization3.94B
ACOG vs BLTE Comparison Chart in %
ACOG
Daily Signal:
Gain/Loss:
BLTE
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ACOG vs. BLTE commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACOG is a StrongBuy and BLTE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (ACOG: $6.13 vs. BLTE: $112.41)
Brand notoriety: ACOG and BLTE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACOG: 75% vs. BLTE: 58%
Market capitalization -- ACOG: $122.7M vs. BLTE: $3.94B
ACOG [@Biotechnology] is valued at $122.7M. BLTE’s [@Biotechnology] market capitalization is $3.94B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACOG’s FA Score shows that 1 FA rating(s) are green whileBLTE’s FA Score has 0 green FA rating(s).

  • ACOG’s FA Score: 1 green, 4 red.
  • BLTE’s FA Score: 0 green, 5 red.
According to our system of comparison, both ACOG and BLTE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACOG’s TA Score shows that 5 TA indicator(s) are bullish while BLTE’s TA Score has 2 bullish TA indicator(s).

  • ACOG’s TA Score: 5 bullish, 4 bearish.
  • BLTE’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, ACOG is a better buy in the short-term than BLTE.

Price Growth

ACOG (@Biotechnology) experienced а +7.54% price change this week, while BLTE (@Biotechnology) price change was +0.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.47%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +62.00%.

Reported Earning Dates

BLTE is expected to report earnings on Mar 27, 2026.

Industries' Descriptions

@Biotechnology (+1.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLTE($3.94B) has a higher market cap than ACOG($123M). BLTE YTD gains are higher at: 78.146 vs. ACOG (4.075). ACOG has higher annual earnings (EBITDA): -19.78M vs. BLTE (-50.43M). ACOG has higher revenues than BLTE: ACOG (4.59M) vs BLTE (0).
ACOGBLTEACOG / BLTE
Capitalization123M3.94B3%
EBITDA-19.78M-50.43M39%
Gain YTD4.07578.1465%
P/E RatioN/AN/A-
Revenue4.59M0-
Total Cash39.4MN/A-
Total Debt2.21MN/A-
TECHNICAL ANALYSIS
Technical Analysis
ACOGBLTE
RSI
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
75%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
69%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 1 day ago
78%
Declines
ODDS (%)
Bearish Trend 18 days ago
85%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
78%
Aroon
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
ACOG
Daily Signal:
Gain/Loss:
BLTE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FSMAX101.36N/A
N/A
Fidelity Extended Market Index
WBELX11.88-0.03
-0.25%
William Blair Emerging Mkts Ldrs I
FBLAX12.86-0.04
-0.31%
Franklin Managed Income A
PMPCX16.00-0.31
-1.90%
Putnam Sustainable Future C
WSGRX12.85-0.46
-3.46%
Macquarie Small Cap Growth R

ACOG and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACOG has been loosely correlated with VRCA. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ACOG jumps, then VRCA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACOG
1D Price
Change %
ACOG100%
+0.16%
VRCA - ACOG
35%
Loosely correlated
+1.31%
NGNE - ACOG
30%
Poorly correlated
-14.77%
CUE - ACOG
28%
Poorly correlated
-7.19%
RGNX - ACOG
27%
Poorly correlated
+0.34%
ZLAB - ACOG
27%
Poorly correlated
-0.69%
More

BLTE and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLTE has been loosely correlated with RAIN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BLTE jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLTE
1D Price
Change %
BLTE100%
+1.44%
RAIN - BLTE
48%
Loosely correlated
+6.10%
ACOG - BLTE
26%
Poorly correlated
+0.16%
ROIV - BLTE
23%
Poorly correlated
-3.56%
AGIO - BLTE
22%
Poorly correlated
-2.50%
APLS - BLTE
22%
Poorly correlated
-1.05%
More